These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 12444808

  • 1. The impact of treatment-resistant depression on health care utilization and costs.
    Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ, Russell JM.
    J Clin Psychiatry; 2002 Nov; 63(11):963-71. PubMed ID: 12444808
    [Abstract] [Full Text] [Related]

  • 2. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK, Kruzikas DT, McLaughlin TP.
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [Abstract] [Full Text] [Related]

  • 3. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD, Zhu B, Ascher-Svanum H, Ball DE.
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Health care utilization and its costs for depressed veterans with and without comorbid PTSD symptoms.
    Chan D, Cheadle AD, Reiber G, Unützer J, Chaney EF.
    Psychiatr Serv; 2009 Dec; 60(12):1612-7. PubMed ID: 19952151
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV, Keene MS, Eaddy M, Krulewicz S, Kraus JE, Carpenter DJ.
    CNS Drugs; 2008 Dec; 22(11):963-73. PubMed ID: 18840035
    [Abstract] [Full Text] [Related]

  • 11. A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.
    Li G, Zhang L, DiBernardo A, Wang G, Sheehan JJ, Lee K, Reutfors J, Zhang Q.
    PLoS One; 2020 Dec; 15(9):e0238843. PubMed ID: 32915863
    [Abstract] [Full Text] [Related]

  • 12. Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population.
    Guo JJ, Keck PE, Li H, Jang R, Kelton CM.
    Value Health; 2008 Dec; 11(3):416-23. PubMed ID: 18179673
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Misdiagnosis of bipolar disorder as borderline personality disorder: clinical and economic consequences.
    John H, Sharma V.
    World J Biol Psychiatry; 2009 Dec; 10(4 Pt 2):612-5. PubMed ID: 19224409
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Health care utilization and costs among privately insured patients with bipolar I disorder.
    Bryant-Comstock L, Stender M, Devercelli G.
    Bipolar Disord; 2002 Dec; 4(6):398-405. PubMed ID: 12519100
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.